Valuation: ConvaTec Group Plc

Capitalization 6.45B 5.57B 5.05B 4.85B 8.84B 592B 9.23B 59.72B 23.86B 284B 24.19B 23.68B 1,017B P/E ratio 2025
38.1x
P/E ratio 2026 * 23.5x
Enterprise value 7.62B 6.59B 5.97B 5.73B 10.45B 700B 10.91B 70.59B 28.21B 335B 28.6B 27.98B 1,202B EV / Sales 2025
2.62x
EV / Sales 2026 * 2.92x
Free-Float
80.35%
Yield 2025 *
2.12%
Yield 2026 * 2.32%
1 day+2.43%
1 week-1.27%
Current month-3.04%
1 month+10.20%
3 months+9.42%
6 months+4.02%
Current year+2.22%
1 week 234.4
Extreme 234.4
257.2
1 month 219.4
Extreme 219.4
259.3
Current year 209.4
Extreme 209.4
259.3
1 year 209.4
Extreme 209.4
311.2
3 years 195.1
Extreme 195.1
311.2
5 years 165.3
Extreme 165.3
311.2
10 years 113.25
Extreme 113.25
349.1
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
President 65 2020-01-31
Director TitleAgeSince
Director/Board Member 71 2017-08-13
Chairman 77 2019-09-29
Director/Board Member 62 2020-03-01
Change 5d. change 1-year change 3-years change Capi.($)
+2.22%-1.27%-2.36%+9.71% 6.33B
-1.91%-4.78%-19.61%+7.74% 197B
-2.85%-4.40%-1.38%+13.22% 123B
-2.50%-2.00%+42.85%+129.64% 71.62B
+2.64%-2.85%+55.94%+105.25% 58.8B
-1.46%-4.80%-24.96%-28.80% 48.83B
+1.66%-11.52% - - 34.8B
-2.92%-4.91%-13.70%-37.55% 28.06B
-1.86%-6.56%+4.64%+27.84% 23.84B
-2.68%-7.90%-11.20%-25.36% 18.73B
Average -0.94%-3.20%+3.36%+22.41% 61.03B
Weighted average by Cap. -1.51%-2.31%+1.07%+28.51%

Financials

2025 2026 *
Net sales 2.43B 2.1B 1.9B 1.83B 3.33B 223B 3.48B 22.51B 8.99B 107B 9.12B 8.92B 383B 2.56B 2.22B 2.01B 1.93B 3.52B 236B 3.67B 23.76B 9.5B 113B 9.63B 9.42B 405B
Net income 241M 209M 189M 182M 331M 22.17B 346M 2.24B 894M 10.62B 906M 887M 38.09B 281M 243M 220M 211M 385M 25.77B 402M 2.6B 1.04B 12.35B 1.05B 1.03B 44.27B
Net Debt 1.17B 1.01B 919M 882M 1.61B 108B 1.68B 10.87B 4.34B 51.62B 4.4B 4.31B 185B 1.05B 908M 822M 789M 1.44B 96.39B 1.5B 9.72B 3.89B 46.18B 3.94B 3.86B 166B
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (32.4%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence (21.9%); - infusion (18%). At the end of 2024, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (28.9%), Americas (56.6%) and Asia/Pacific (14.5%).
Employees
10,000
Date Price Change Volume
26-03-05 248.60 p +2.22% 7,955,867
26-03-04 243.20 p +2.44% 11,793,190
26-03-03 237.40 p -3.57% 8,449,234
26-03-02 246.20 p -3.98% 8,306,181
26-02-27 256.40 p +0.16% 8,602,532
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
3.250USD
Average target price
4.145USD
Spread / Average Target
+27.54%

Quarterly revenue - Rate of surprise